Dr Reddy's Q2 FY24 PAT jumps 33% to Rs 1,480 Cr
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Minister was briefed on the nationwide dengue situation
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Commenced operations in flood-affected Himachal Pradesh
Subscribe To Our Newsletter & Stay Updated